| 04.04.2024 10:44 | GENI | CARDIO inCode-Score® US study publication | RNS |
| 21.03.2024 12:01 | GENI | GENinCode says ROCA recommended as ovarian cancer risk test in England | Alliance |
| 21.03.2024 10:58 | GENI | New NICE Guidance for Ovarian Cancer | RNS |
| 15.01.2024 07:00 | GENI | Holding(s) in Company | RNS |
| 11.01.2024 14:49 | GENI | Holding(s) in Company | RNS |
| 11.01.2024 14:30 | GENI | Holding(s) in Company | RNS |
| 09.01.2024 13:30 | GENI | Result of GM and Total Voting Rights | RNS |
| 02.01.2024 15:32 | LDSG, GENI, AGTA | UK shareholder meetings calendar - next 7 days | Alliance |
| 28.12.2023 08:49 | GENI | IN BRIEF: GENinCode gets GBP57,000 in retail offer, well below maximum | Alliance |
| 28.12.2023 07:00 | GENI | Result of Retail Offer | RNS |
| 21.12.2023 21:54 | GENI | IN BRIEF: GENinCode raises GBP4 million via placing and subscription | Alliance |
| 21.12.2023 18:25 | GENI | Result of Placing and Subscription | RNS |
| 21.12.2023 16:59 | GENI | Retail Offer | RNS |
| 21.12.2023 16:55 | GENI | Placing and Subscription | RNS |
| 29.11.2023 18:07 | GENI, ARV, KAV | TRADING UPDATES: Aura eyes Tiris expansion; Kavango backs Pambili | Alliance |
| 29.11.2023 07:10 | GENI | CARDIO inCode-Score 510(k) FDA submission update | RNS |
| 29.11.2023 07:00 | GENI | Change of Adviser | RNS |
| 12.10.2023 07:00 | GENI | ShareSoc investor presentation | Reach |
| 20.09.2023 16:24 | TAVI, PXEN, MYX | EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up | Alliance |
| 20.09.2023 07:00 | GENI | Half-year Report | RNS |
| 13.09.2023 15:48 | W7L, SUPR, PYX | UK earnings, trading statements calendar - next 7 days | Alliance |
| 13.09.2023 07:00 | GENI | Notice of Results | RNS |
| 30.08.2023 07:00 | GENI | Presentation at European Society of Cardiology | RNS |
| 16.08.2023 10:27 | GENI | CARDIO inCode 510k filing | RNS |
| 19.07.2023 11:15 | GENI | GENinCode and MedStar collaborate on coronary heart disease testing | Alliance |
| 19.07.2023 07:00 | GENI | Collaboration with US healthcare provider | RNS |
| 30.06.2023 16:03 | GENI | Result of AGM | RNS |
| 23.06.2023 15:51 | CHSS, URAH, STG | UK shareholder meetings calendar - next 7 days | Alliance |
| 08.06.2023 13:31 | GENI | Notice of AGM and posting of Annual Report | RNS |
| 06.06.2023 14:30 | GENI | GENinCode annual loss widens; focuses on US, EU, and NHS in UK | Alliance |
| 06.06.2023 07:00 | GENI | Final Results | RNS |
| 05.06.2023 07:00 | GENI | Notice of Results | RNS |
| 22.05.2023 07:00 | GENI | CARDIO inCode be presented at conference | RNS |
| 15.05.2023 18:13 | OBD, TRR, GENI | TRADING UPDATES: Trident Royalties takes interest in Mexican project | Alliance |
| 15.05.2023 07:00 | GENI | Collaboration with University Clinic Dresden | RNS |
| 02.05.2023 12:09 | GENI | UK National Health Service to hike use of GENinCode heart disease test | Alliance |
| 02.05.2023 11:00 | PHC, MTEC, LBE | AIM WINNERS & LOSERS: Longboat Energy signs Japex joint-venture deal | Alliance |
| 02.05.2023 07:00 | GENI | NHS LIPID inCode testing implementation | RNS |
| 03.04.2023 16:41 | HARL, NSCI, TENT | TRADING UPDATES: GENinCode gets US boost; Cindrigo strikes deal | Alliance |
| 03.04.2023 07:00 | GENI | CARDIO InCode CPT PLA Code | RNS |
| 13.03.2023 12:18 | VRCI, CSFS, SCLP | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
| 13.03.2023 07:00 | GENI | Statement re: Silicon Valley Bank | RNS |
| 03.01.2023 16:40 | GENI | Second Price Monitoring Extn | RNS |
| 03.01.2023 16:35 | GENI | Price Monitoring Extension | RNS |
| 03.01.2023 11:07 | HE1, SHEL, CEG | AIM WINNERS & LOSERS: GENinCode shares soar on US approvals | Alliance |
| 03.01.2023 10:38 | GENI | GENinCode shares surge amid state licence approval for California lab | Alliance |
| 03.01.2023 07:00 | GENI | Approval of California state license | RNS |
| 22.11.2022 14:07 | GENI | Issue of Share Options | RNS |
| 03.11.2022 07:00 | GENI | British Medical Journal publication | RNS |
| 10.10.2022 18:23 | TV1, GENI | Holding(s) in Company | RNS |
| 27.09.2022 17:42 | LIFS, GENI, CZN | EARNINGS UPDATES: Transence Tech swings to profit; Curzon widens loss | Alliance |
| 27.09.2022 07:00 | GENI | Half-year report | RNS |
| 20.09.2022 15:52 | TRT, TBLD, SSPG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 07.09.2022 07:00 | GENI | Notice of results | RNS |
| 26.07.2022 22:16 | JARA, RCOI, OCI | TRADING UPDATES: De La Rue cancels contract; Apollon buys in Jamaica | Alliance |
| 26.07.2022 07:00 | GENI | NHS implementation of Lipid inCode testing | RNS |
| 23.06.2022 14:37 | GENI | Result of AGM | RNS |
| 16.06.2022 16:03 | ZNWD, TND, RBGP | UK shareholder meetings calendar - next 7 days | Alliance |
| 23.05.2022 16:06 | GENI | Posting of Annual Report and Notice of AGM | RNS |
| 17.05.2022 12:18 | GENI, VIC, MYX | TRADING UPDATES: Victorian Plumbing profit drops; Renew hikes dividend | Alliance |
| 17.05.2022 07:00 | GENI | Final Results | RNS |
| 10.05.2022 16:04 | MRC, MER, KEFI | UK shareholder meetings calendar - next 7 days | Alliance |
| 03.05.2022 07:00 | GENI | Notice of Results | RNS |
| 06.04.2022 07:00 | GENI | Director Appointment | RNS |
| 23.03.2022 20:53 | TERN, CHRT, PALM | TRADING UPDATES: Arecor Therapeutics wins patent approval in US | Alliance |
| 23.03.2022 07:00 | GENI | Indiana University Medical School collaboration | RNS |
| 15.03.2022 19:45 | GENI, TRX, VINO | TRADING UPDATES: Hyve exits Russia; Genel revenue rises in 2021 | Alliance |
| 15.03.2022 07:00 | GENI | Lipid inCode pilot | RNS |
| 21.02.2022 13:17 | GENI | Confirmation of board appointment | RNS |
| 08.02.2022 07:00 | GENI | Positive results for Lipid inCode in NHS study | RNS |
| 21.01.2022 07:00 | GENI | Proposed independent directorate appointment | RNS |
| 10.01.2022 07:00 | GENI | FDA Pre-Submission for Cardio inCode-SCORE | RNS |
| 29.11.2021 07:00 | GENI | Directorate Change | RNS |
| 25.11.2021 07:00 | GENI | Trading update | RNS |
| 17.09.2021 10:38 | GENI | Grant of Share Options and PDMR dealing | RNS |
